Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT.

Fiche publication

Date publication

avril 2025

Journal

BMC cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CAILLOT Denis , Pr RUBIO Marie Thérèse

Tous les auteurs :
Swoboda R, Labopin M, Giebel S, Maertens J, Parovichnikova E, Versluis J, Pavlu J, Kopinska A, Capria S, Raida L, Rambaldi A, Caillot D, Folber F, Nachbaur D, Ozturk M, Aljurf M, Rubio MT, Gorin NC, Lanza F, Nagler A, Mohty M, Ciceri F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40289118

Résumé

The role of autologous hematopoietic stem cell transplantation (AHSCT) in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph-ALL) remains controversial. The aim of this retrospective study was to analyze results of AHSCT and to identify prognostic factors.